SCHEMBL30522043

SCHEMBL30522043

CCc1noc2cc(OC)c(-c3cccc(S(N)(=O)=O)c3OC)cc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 6/20 0.38
▸ CA9 Q16790 6/20 0.38
▸ CA1 P00915 5/20 0.38
▸ CA12 O43570 4/20 0.38
▸ MAPT P10636 1/20 0.37
▸ BRD4 O60885 5/20 0.36
▸ CA4 P22748 3/20 0.36
▸ CTSG P08311 1/20 0.35
▸ KLK7 P49862 1/20 0.35
▸ KLK14 Q9P0G3 1/20 0.35
▸ KLK5 Q9Y337 1/20 0.35
▸ KAT6A Q92794 4/20 0.34
▸ KAT7 O95251 3/20 0.34
▸ KAT6B Q8WYB5 2/20 0.34
▸ CA13 Q8N1Q1 2/20 0.33
▸ LMNA P02545 1/20 0.33
▸ CA3 P07451 1/20 0.33
▸ CA6 P23280 1/20 0.33
▸ MAOB P27338 1/20 0.33
▸ CA5A P35218 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30522048 0.90 BRD4 (0.40) CA2CA9CA1CA12MAPT
SCHEMBL30522038 0.90 CA2 (0.35) CA2CA9CA1CA12MAPT
SCHEMBL30522050 0.89 CA4 (0.39) CA2CA9CA1CA12BRD4
SCHEMBL30522039 0.85 CA4 (0.38) CA2CA9CA1CA12MAPT
SCHEMBL30522040 0.83 CA4 (0.38) CA2CA9CA1CA12MAPT
SCHEMBL30522047 0.82 CA4 (0.38) CA2CA9CA1CA12MAPT
SCHEMBL30522049 0.82 CA2 (0.40) CA2CA9CA1CA12BRD4
SCHEMBL30522035 0.81 BRD4 (0.39) CA2CA9CA1CA12BRD4
SCHEMBL30522033 0.80 MEN1 (0.37) CA2CA9CA1CA12MAPT
SCHEMBL30522041 0.79 CA2 (0.39) CA2CA9CA1CA12MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113651766-B Isoxazole sulfonamide compound with BRD4 inhibitory activity, and preparation method and application thereof 泰州职业技术学院 2023-08-18 — — CN disclosed
Send feedback